Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.
Clinical trial NCT06479954 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06479954
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-30
- Primary completion
- 2027-02-25
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.